Kestrel Group Reports First Quarter 2026 Financial Results

Go back to Kestrel Group Reports First Quarter 2026 Financial Results
KING PHARMACEUTICALS (NASDAQ: KG) Delayed: 4.29 +0.07 (1.66%)
Previous Close $4.22    52 Week High $14.26 
Open $4.29    52 Week Low $7.18 
Day High $4.29    P/E 12.62 
Day Low $4.29    EPS $0.34 
Volume 417